179 related articles for article (PubMed ID: 22888643)
1. [Complications of radiotherapy for non-small cell lung cancer and their influence on the results of combined therapy].
Ragulin IuA
Vopr Onkol; 2012; 58(3):303-11. PubMed ID: 22888643
[No Abstract] [Full Text] [Related]
2. Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the radiation therapy oncology group (RTOG) database.
Werner-Wasik M; Paulus R; Curran WJ; Byhardt R
Clin Lung Cancer; 2011 Jul; 12(4):245-51. PubMed ID: 21726824
[TBL] [Abstract][Full Text] [Related]
3. [Adjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
Papadakis E
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S25-8. PubMed ID: 11924238
[No Abstract] [Full Text] [Related]
4. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
Mornex F
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
[No Abstract] [Full Text] [Related]
5. [Endoscopic findings of esophagitis in concurrent chemo-radiotherapy for lung cancer].
Watanabe H; Hirota S; Soejima T; Honda K; Kono K; Hishikawa Y; Obayasi K; Takada Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1998 May; 58(6):271-6. PubMed ID: 9656695
[TBL] [Abstract][Full Text] [Related]
6. [Combined multimodality treatment for non-small cell lung cancer--with special reference to pre- and post-operative adjuvant therapy].
Watanabe Y
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2555-63. PubMed ID: 7979413
[TBL] [Abstract][Full Text] [Related]
7. Perioperative therapy of non-small cell lung cancer: a review of adjuvant and neoadjuvant approaches.
Friedland DM; Comis RL
Semin Oncol; 1995 Dec; 22(6):571-81. PubMed ID: 8539633
[No Abstract] [Full Text] [Related]
8. Clinical and dosimetric risk factors of acute esophagitis in patients treated with 3-dimensional conformal radiotherapy for non-small-cell lung cancer.
Zhang ZC; Xu J; Li BS; Zhou T; Lu J; Wang ZT; Li HS; Sun HF; Zhu J; Yu JM
Am J Clin Oncol; 2010 Jun; 33(3):271-5. PubMed ID: 19823071
[TBL] [Abstract][Full Text] [Related]
9. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
Bozóky G; Ruby E; Góhér I; Gábor G; Mohos A; Lengyel M
Orv Hetil; 2005 Jul; 146(27):1433-8. PubMed ID: 16089103
[TBL] [Abstract][Full Text] [Related]
10. Gender difference in treatment outcomes in patients with stage III non-small cell lung cancer receiving concurrent chemoradiotherapy.
Sekine I; Sumi M; Ito Y; Tanai C; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
Jpn J Clin Oncol; 2009 Nov; 39(11):707-12. PubMed ID: 19692418
[TBL] [Abstract][Full Text] [Related]
11. Different fraction schedules and combinations with chemotherapy in radiation treatment of non-small cell lung cancer.
Brattström D; Bergqvist M; Hesselius P; Wagenius G; Brodin O
Anticancer Res; 2000; 20(3B):2087-90. PubMed ID: 10928157
[TBL] [Abstract][Full Text] [Related]
12. Analysis of acute radiation-induced esophagitis in non-small-cell lung cancer patients using the Lyman NTCP model.
Zhu J; Zhang ZC; Li BS; Liu M; Yin Y; Yu JM; Luo LM; Shu HZ; De Crevoisier R
Radiother Oncol; 2010 Dec; 97(3):449-54. PubMed ID: 21067834
[TBL] [Abstract][Full Text] [Related]
13. [Postoperative radiotherapy in non-small cell lung cancer].
Roelandts M; Moretti L; Van Houtte P
Cancer Radiother; 2011 Oct; 15(6-7):514-7. PubMed ID: 21820931
[TBL] [Abstract][Full Text] [Related]
14. [Does chemotherapy improve the results of postoperative radiotherapy in completely resected stage II and IIIA non-small-cell bronchial cancer?].
Baumann M
Strahlenther Onkol; 2001 Apr; 177(4):220-1. PubMed ID: 11370558
[No Abstract] [Full Text] [Related]
15. [Neoadjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
Moro D
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S22-4. PubMed ID: 11924237
[No Abstract] [Full Text] [Related]
16. Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer.
Choy H; LaPorte K; Knill-Selby E; Mohr P; Shyr Y
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):90-6. PubMed ID: 10210546
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant versus adjuvant therapy for resectable non-small-cell lung cancer.
Belani CP
Clin Lung Cancer; 2004 Jul; 6(1):8. PubMed ID: 15310410
[No Abstract] [Full Text] [Related]
18. [Survival analysis and prognosis of lung cancer related factors].
Fan ZM; Shu ZG; Tan JP
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jun; 27(6):674-5. PubMed ID: 21882475
[TBL] [Abstract][Full Text] [Related]
19. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Qian H; Wang LJ; Yang HJ; Fu XL; Wu KL; Zang Z; Zhao S
Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer adjuvant therapy.
Horn L; Sandler A
Cancer J; 2007; 13(3):210-6. PubMed ID: 17620772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
